Barclays raises target for Recordati stock to EUR 56.00
Published on 10/26/2026 at 16:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and dates
- Barclays raised its Recordati target from EUR 55.00 to EUR 56.00 on October 21, 2026.
- Recordati is scheduled to publish third-quarter results on November 9, 2026.
- Recordati stock costs EUR 53.03 at Lang & Schwarz on October 26, 2026, 1.43 percent below the Borsa Italiana close of October 23, 2026.
Barclays raised its target for Recordati stock from EUR 55.00 to EUR 56.00 while keeping an Equalweight rating on October 21, 2026, according to Teleborsa. Recordati stock was trading at EUR 53.03 at Lang & Schwarz on October 26, 2026 at 4:28 p.m. CEST, 1.43 percent below the Borsa Italiana close of October 23, 2026.
Barclays lifts its target
The revised EUR 56.00 target is EUR 1.00 above the previous EUR 55.00 level. At EUR 53.03, the target lies 5.60 percent above the Lang & Schwarz price, using the same euro currency.
The rating remained Equalweight, so the change was a valuation adjustment rather than a shift to a more positive recommendation. Teleborsa also cited EUR 52.98 as a short-term resistance level in its October 21 report.
Price stays near the offer
Recordati's October 26 euro price was EUR 0.03 above the EUR 53.00 offer consideration described in the takeover coverage. The price was 1.43 percent below the Borsa Italiana close of October 23, 2026, at EUR 53.80.
Recordati published provisional results dated October 23, 2026 and set the reopening period for November 3 through November 9. The company release identified the 66.67 percent acceptance threshold for the offer.
Results date and market value
MarketScreener lists November 9, 2026 as Recordati's next earnings release date and reports a market capitalization of EUR 12.34 billion, both alongside the October 23 market close. The same page identifies Recordati as a pharmaceutical company listed on Borsa Italiana under ticker REC and shows eight analysts with an average target of EUR 58.22.
The November results date gives the next scheduled checkpoint for the analyst view. The EUR 56.00 Barclays target remains below the EUR 58.22 average shown by MarketScreener.
What comes next for Recordati
The immediate calendar is defined by the November 3 to November 9 reopening period and the November 9 results date. For investors, the key numerical tension is between the EUR 53.00 offer, Barclays' EUR 56.00 target and the EUR 58.22 average target.
Recordati stock after the target revision
Recordati stock stood at EUR 53.03 at Lang & Schwarz on October 26, 2026 at 4:28 p.m. CEST, down 1.43 percent against the Borsa Italiana close of EUR 53.80 on October 23, 2026. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.
Recordati stock at a glance
- Company: Recordati S.p.A.
- ISIN: IT0003828271
- Ticker: REC
- Primary exchange: Borsa Italiana
- Price Lang & Schwarz (as of October 26, 2026, 4:28 p.m. CEST): EUR 53.03
- Change versus Borsa Italiana close: minus 1.43 percent
- Borsa Italiana close (October 23, 2026): EUR 53.80
- Market capitalization: EUR 12.3 billion (as of October 23, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: FTSE MIB
- Next earnings date: November 9, 2026
Market context: Market report FTSE MIB.
